301 Saint Paul Place, Baltimore, MD, 21202 · (410) 332-9237
Beds
171
FY 2025
Star rating
3 of 5
Patient survey: 3 of 5
Net patient revenue
$606.5M
FY 2025
Net income
$36.4M
Patient care margin -6.3%
Discharges
12,075
Occupancy 84.2%
Clinicians
571
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $606.5M | $644.6M | -6.3% | $36.4M | 12,075 | $29.4M | 19.4% | 4.8% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for COPD patients | 8.4% | US median 8.5% |
| Death rate for heart failure patients | 10.1% | US median 11% |
| Hospital-wide death rate within 30 days | 3.8% | US median 3.9% |
| Death rate for pneumonia patients | 17.9% | US median 15.2% |
| Death rate for stroke patients | 13.1% | US median 11.6% |
| Readmission rate for COPD | 20.7% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $580.9M | $605.6M | -4.3% | $46.5M | 12,153 | $26.0M | 21.0% | 5.1% |
| 2023 | $561.3M | $579.8M | -3.3% | $63.4M | 11,175 | $24.1M | 20.2% | 4.0% |
| 2022 | $550.0M | $549.1M | 0.1% | -$5.5M | 9,298 | $21.0M | 21.8% | 4.0% |
| 2021 | $536.8M | $531.5M | 1.0% | $106.2M | 10,527 | $20.1M | 21.9% | 3.1% |
| 2020 | $471.8M | $496.6M | -5.3% | $4.6M | 11,791 | $24.6M | 24.6% | 4.4% |
| US median 19.8% |
| Readmission rate for heart failure | 21.8% | US median 21.3% |
| Readmission rate after hip or knee replacement | 6.3% | US median 5.8% |
| Readmission rate for pneumonia | 17.5% | US median 17.2% |
| Complications after hip or knee replacement | 5.3% | US median 4.1% |
| Serious complications (patient safety composite) | 1.00 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.79 | US median 0.28 |
| Central line bloodstream infections (ratio to expected) | 0.57 | US median 0.48 |
| Surgical site infections after colon surgery (ratio to expected) | 0.46 | US median 0.72 |
| Surgical site infections after hysterectomy (ratio to expected) | 0.13 | US median 0.81 · better |
| MRSA bloodstream infections (ratio to expected) | 0.00 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.77 | US median 0.40 |
| Doctors always communicated well | 78% | US median 79% |
| Nurses always communicated well | 77% | US median 80% |
| Patient survey summary star rating | 3 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 61% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 72% | US median 72% |
| Room and bathroom always clean | 75% | US median 73% |
| Patients who would definitely recommend the hospital | 80% | US median 71% |
| Median time in the emergency department before leaving (minutes) | 237 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 13% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 91% | US median 65% |
| Healthcare workers given the flu vaccine | 98% | US median 79% |
| Stroke patients who got a brain scan within 45 minutes of arrival | 83% | US median 74% |
| 48 |
| $32,090.15 |
| $24,268.88 |
| $15,524.21 |
| DRG 330 MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH CC | 39 | $42,764.64 | $33,364.31 | $18,026.21 |
| DRG 392 ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MCC | 37 | $17,026.78 | $13,251.27 | $5,662.18 |
| DRG 690 KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC | 32 | $12,988.22 | $10,042.63 | $5,985.69 |
| DRG 467 REVISION OF HIP OR KNEE REPLACEMENT WITH CC | 30 | $37,692.27 | $29,708.13 | $26,100.04 |
| DRG 552 MEDICAL BACK PROBLEMS WITHOUT MCC | 30 | $12,765.83 | $9,813.97 | $7,114.44 |
| DRG 455 COMBINED ANTERIOR AND POSTERIOR SPINAL FUSION WITHOUT CC/MCC | 29 | $54,611.97 | $39,797.55 | $33,846.56 |
| DRG 470 MAJOR HIP AND KNEE JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MCC | 29 | $27,820.76 | $22,031.97 | $14,289.25 |
| DRG 472 CERVICAL SPINAL FUSION WITH CC | 29 | $36,025.07 | $27,447.45 | $22,616.88 |
| DRG 640 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC | 28 | $24,708.82 | $20,196.64 | $10,642.23 |
| DRG 641 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC | 28 | $18,418.04 | $13,855.54 | $5,829.71 |
| DRG 603 CELLULITIS WITHOUT MCC | 27 | $17,059.33 | $13,032.44 | $6,446.25 |
| DRG 253 OTHER VASCULAR PROCEDURES WITH CC | 27 | $42,507.11 | $32,768.22 | $20,750.67 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 8 | $418K |
| Olympus Corporation of the Americas | 7 | $371K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $283K |
| Pfizer Inc. PFE | 18 | $228K |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $111K |
| Intuitive Surgical, Inc. ISRG | 2 | $50K |
| Baxter Healthcare BAX | 1 | $45K |
| Gilead Sciences, Inc. GILD | 4 | $14K |
| AngioDynamics, Inc. ANGO | 1 | $13K |
| Stryker Corporation SYK | 3 | $10K |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Mercy Medical Center Inc is a nonprofit short-term acute care hospital in Baltimore, MD with 171 beds, part of Mercy Medical Center and a 3-star overall rating.
Mercy Medical Center Inc in Baltimore, MD has 171 beds (fiscal year 2025 cost report); 285 beds are certified for Medicare. It discharged 12,075 inpatients that year, with 84.2% of its beds in use on average.
In fiscal year 2025 (ending 2025-06-30), Mercy Medical Center Inc reported net patient revenue of $606.5M and operating expenses of $644.6M, a margin on patient care of -6.3%. After other income and expenses its net income was $36.4M (5.3% of revenue), so it made a profit that year.
Mercy Medical Center Inc is part of Mercy Medical Center, a health system with 1 hospitals based in Baltimore, MD. It is a nonprofit hospital.
Mercy Medical Center Inc has an overall rating of 3 out of 5 stars in the official hospital quality ratings. Patients rate it 3 out of 5 stars in the patient survey.
Yes, Mercy Medical Center Inc provides emergency services.
571 Medicare clinicians list Mercy Medical Center Inc as a hospital they work at, most often in Internal Medicine, Physician Assistant, Nurse Practitioner.
In 2024, Mercy Medical Center Inc had 1,234 Medicare inpatient stays in 58 diagnosis groups. The most common was DRG 454 (combined anterior and posterior spinal fusion with cc) with 127 stays; Medicare paid $43,240.02 per stay on average, compared with $49,528.71 across all hospitals.
In 2025, companies reported $1.6M in payments to Mercy Medical Center Inc as a teaching hospital ($999K general and $633K for research) from 27 companies.